A global perspective on the status of clinical metabolomics in laboratory medicine - a survey by the IFCC metabolomics working group

被引:1
|
作者
Fux, Elie [1 ]
Lenski, Marie [2 ,3 ]
Bendt, Anne K. [4 ]
Otvos, James D. [5 ]
Ivanisevic, Julijana [6 ]
De Bruyne, Sander [7 ]
Cavalier, Etienne [8 ]
Friedecky, David [9 ,10 ]
机构
[1] Roche Diagnost GmbH, Nonnenwald 2, Penzberg, Germany
[2] Univ Lille, IMPECS IMPact Environm Chim Sante Humaine, CHU Lille, Inst Pasteur Lille,ULR 4483, F-59000 Lille, France
[3] CHU Lille, Unite Fonct Toxicol, Lille, France
[4] Natl Univ Singapore, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore
[5] NHLBI, NIH, Translat Vasc Med Branch, Lipoprot Metab Lab, Bethesda, MD USA
[6] Univ Lausanne, Fac Biol & Med, Metabol Unit, Lausanne, Switzerland
[7] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium
[8] Univ Liege, CHU Liege, Dept Clin Chem, CIRM, Liege, Belgium
[9] Univ Hosp Olomouc, Dept Clin Biochem, Zdravotniku 7, Olomouc 77900, Czech Republic
[10] Palacky Univ Olomouc, Fac Med & Dent, Olomouc, Czech Republic
关键词
clinical metabolomics; clinical lipidomics; emerging technologies; diagnostics; prognostics; laboratory medicine; CORONARY-ARTERY-DISEASE; CERAMIDES; TOOL;
D O I
10.1515/cclm-2024-0550
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Metabolomics aims for comprehensive characterization and measurement of small molecule metabolites (<1700 Da) in complex biological matrices. This study sought to assess the current understanding and usage of metabolomics in laboratory medicine globally and evaluate the perception of its promise and future implementation. Methods: A survey was conducted by the IFCC metabolomics working group that queried 400 professionals from 79 countries. Participants provided insights into their experience levels, knowledge, and usage of metabolomics approaches, along with detailing the applications and methodologies employed. Results: Findings revealed a varying level of experience among respondents, with varying degrees of familiarity and utilization of metabolomics techniques. Targeted approaches dominated the field, particularly liquid chromatography coupled to a triple quadrupole mass spectrometer, with untargeted methods also receiving significant usage. Applications spanned clinical research, epidemiological studies, clinical diagnostics, patient monitoring, and prognostics across various medical domains, including metabolic diseases, endocrinology, oncology, cardiometabolic risk, neurodegeneration and clinical toxicology. Conclusions: Despite optimism for the future of clinical metabolomics, challenges such as technical complexity, standardization issues, and financial constraints remain significant hurdles. The study underscores the promising yet intricate landscape of metabolomics in clinical practice, emphasizing the need for continued efforts to overcome barriers and realize its full potential in patient care and precision medicine.
引用
收藏
页码:1950 / 1961
页数:12
相关论文
共 50 条
  • [1] A global perspective on the status of clinical metabolomics
    Fux, E.
    Bendt, A. K.
    Cavalier, E.
    De Bruyne, S.
    Friedecky, D.
    Ivanisevic, J.
    Lenski, M.
    Otvos, J.
    CLINICA CHIMICA ACTA, 2024, 558
  • [2] Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group
    Master, Stephen R.
    Badrick, Tony C.
    Bietenbeck, Andreas
    Haymond, Shannon
    CLINICAL CHEMISTRY, 2023, 69 (07) : 690 - 698
  • [3] Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project
    Sciacovelli, Laura
    Lippi, Giuseppe
    Sumarac, Zorica
    West, Jamie
    Castro, Isabel Garcia del Pino
    Vieira, Keila Furtado
    Ivanov, Agnes
    Plebani, Mario
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (03) : 348 - 357
  • [5] Metabolomics: A New Perspective to Persian Medicine
    Oskouie, Afsaneh Arefi
    Aliabad, Hossein Soraki
    Zanjani, Rasool Choopani
    Kaveh, Shahpar
    Sadeghi, Sajjad
    Chelavi, Leila Hashemi
    Fayaz, Mohammad
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 498 - 504
  • [6] The IFCC Working Group on laboratory errors and patient safety
    Sciacovelli, Laura
    Plebani, Mario
    CLINICA CHIMICA ACTA, 2009, 404 (01) : 79 - 85
  • [7] The role of metabolomics in neonatal and pediatric laboratory medicine
    Mussap, Michele
    Antonucci, Roberto
    Noto, Antonio
    Fanos, Vassilios
    CLINICA CHIMICA ACTA, 2013, 426 : 127 - 138
  • [8] Metabolomics Applications in Precision Medicine: An Oncological Perspective
    Puchades-Carrasco, Leonor
    Pineda-Lucena, Antonio
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (24) : 2740 - 2751
  • [9] Application of metabolomics in clinical and laboratory gastrointestinal oncology
    Peng Gao
    Xin Huang
    Xue-Yan Fang
    Hui Zheng
    Shu-Ling Cai
    Ai-Jun Sun
    Liang Zhao
    Yong Zhang
    World Journal of Gastrointestinal Oncology, 2021, 13 (06) : 536 - 549
  • [10] Application of metabolomics in clinical and laboratory gastrointestinal oncology
    Gao, Peng
    Huang, Xin
    Fang, Xue-Yan
    Zheng, Hui
    Cai, Shu-Ling
    Sun, Ai-Jun
    Zhao, Liang
    Zhang, Yong
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (06) : 536 - 549